Recent Finacing
Recent Raise
Anocca develops and manufactures TCR‑engineered T‑cell therapies for solid tumours using a proprietary automated discovery platform, integrated bioinformatics (AnoccaOS) and in‑house cGMP process development in Sweden.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Anocca.
